Loading...
Market
How many major competitors will launch OTC CGMs in the U.S. by the end of 2024?
2
Resolution / Starting Odds
None • 25%
1 • 25%
2 • 25%
3 or more • 25%
Press releases and product announcements from major CGM manufacturers
Story
Dexcom Launches First OTC Glucose Monitor in U.S.
Aug 26, 2024, 10:06 AM
Dexcom has launched Stelo, the first over-the-counter continuous glucose monitor (CGM) in the United States. The device, announced earlier this year at CES 2024, aims to provide a more affordable option for people with Type 2 diabetes to access CGMs. The availability of Stelo marks a significant step in the fight against diabetes by improving accessibility to essential monitoring technology.
View original story
Similar markets
More than 3 competitors • 25%
2 to 3 competitors • 25%
1 competitor • 25%
No new competitors • 25%
No new competitors • 25%
1-2 new competitors • 25%
3-4 new competitors • 25%
5+ new competitors • 25%
0 • 25%
1 • 25%
2 • 25%
3 or more • 25%
None • 25%
1-2 • 25%
3-4 • 25%
5 or more • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Top 10 • 25%
Top 20 • 25%
Top 50 • 25%
Outside Top 50 • 25%
0 • 25%
1-2 • 25%
3-4 • 25%
5 or more • 25%
No major competitors • 25%
1 major competitor • 25%
2 major competitors • 25%
3 or more major competitors • 25%
No new competitors • 25%
1 new competitor • 25%
2 new competitors • 25%
3 or more new competitors • 25%
None • 25%
One • 25%
Two • 25%
Three or more • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%